Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC N-[[4-(benzamidocarbamoyl)phenyl]methyl]-3-chloro-4-fluorobenzenesulfonamide | 852918-02-6 | MFCD06683895 | 99.2% | C21H17ClFN3O4S | 10MG
SDP

Supplier:  Medchemexpress LLC HY1345710MG

Encompass_Preferred

TCN 201 is a potent, selective, non-competitive antagonist of GluN1/GluN2A (NR2A-containing) NMDA receptors used as a research tool in neuroscience. It inhibits NR2A-containing receptors with a reported pIC50 ≈ 6.8 and shows markedly lower activity at NR2B-containing receptors. The compound is supplied at high purity and is intended for use in in vitro and in vivo experimental applications.

  • Selective antagonist of NR2A-containing NMDA receptors.
  • Potent activity (pIC50 ≈ 6.8 for NR2A).
  • High chemical purity suitable for research (99.2%).
  • Well characterized molecular properties (C21H17ClFN3O4S, MW 461.89).
  • Useful for electrophysiology, pharmacology, and receptor subtype studies.

Catalog No. 50-002-60049


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.